NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名: ABILIFY MAINTENA KIT (ARIPIPRAZOLE) ANDA: NDA #202971 NDC:59148-019-71 制造公司: OTSUKA PHARM CO LTD 活性物质: ARIPIPRAZOLE 剂量: 400MG/VIAL 使用方式: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 营销状态: Prescription 批准日期: 10/08/2014批准类型: Approval ...
产品名称:MACITENTAN上市时间:04/18/2023NDA/ANDA/BLA:211198持证商:AUROBINDO PHARMA LTDNDC:说明书:批准信:
产品名称:ROFLUMILAST上市时间:04/18/2023NDA/ANDA/BLA:212490持证商:ALKEM LABS LTDNDC:说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212490Orig1s000TAltr.pdf
产品名称:CLOFARABINE上市时间:04/18/2023NDA/ANDA/BLA:213461持证商:MEITHEALNDC:71288-128-20说明书:批准信:
产品名称:CEVIMELINE HYDROCHLORIDE上市时间:04/18/2023NDA/ANDA/BLA:215056持证商:AUROBINDO PHARMANDC:59651-422-01,59651-422-05说明书:批准信:
产品名称:PADCEV上市时间:04/18/2023NDA/ANDA/BLA:761137持证商:ASTELLASNDC:51144-020-01,51144-030-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761137Orig1s000ltr.pdf
产品名称:DIFFERIN上市时间:04/19/2023NDA/ANDA/BLA:22502持证商:GALDERMA LABS LPNDC:0299-5912-01,0299-5912-02说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022502lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022502s000ltr.pdf
产品名称:ONDANSETRON HYDROCHLORIDE上市时间:04/19/2023NDA/ANDA/BLA:77577持证商:WOCKHARDTNDC:说明书:批准信:
产品名称:ONDANSETRON HYDROCHLORIDE上市时间:04/19/2023NDA/ANDA/BLA:77577持证商:WOCKHARDTNDC:说明书:批准信:
产品名称:ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE上市时间:04/19/2023NDA/ANDA/BLA:77716持证商:WOCKHARDTNDC:说明书:批准信:
产品名称:ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE上市时间:04/19/2023NDA/ANDA/BLA:77716持证商:WOCKHARDTNDC:说明书:批准信: